NCT01030094View on ClinicalTrials.gov

A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

April 30, 2009

Study Completion Date

April 30, 2009

Conditions
SeizuresConvulsionsEpilepsyOsteopeniaOsteoporosis
Interventions
DRUG

Topiramate

This is an observational study. Female participants with epilepsy will be observed, who were receiving topiramate for more than one year.

DRUG

Carbamazepine

This is an observational study. Female participants with epilepsy will be observed, who were receiving carbamazepine for more than one year.

DRUG

Valproic acid

This is an observational study. Female participants with epilepsy will be observed, who were receiving valproic acid for more than one year.

DRUG

Normal control

This is an observational study. Healthy female participants will be observed in Normal control group.

All Listed Sponsors
lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01030094 - A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy | Biotech Hunter | Biotech Hunter